ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,423Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 96

$637K Total Retail Price of All Prescriptions

Rank: 22 out of 96

362 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 362 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

4% of this provider’s 362 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 12,194 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 621 607 1 4
LEVOTHYROXINE SODIUM 477 470 2 3
SIMVASTATIN 461 460 3 1
WARFARIN SODIUM 457 449 4 6
DONEPEZIL HCL 414 414 5 8
OMEPRAZOLE 394 394 6 5
NAMENDA 345 345 7 11
METOPROLOL TARTRATE 337 328 8 7
AMLODIPINE BESYLATE 302 301 9 2
POTASSIUM CHLORIDE 295 295 10 19
MIRTAZAPINE 229 229 11 14
FAMOTIDINE 187 187 12 21
ESCITALOPRAM OXALATE 175 173 13 24
LISINOPRIL 169 169 14 10
CARVEDILOL 169 168 14 22
SERTRALINE HCL 167 167 16 15
GABAPENTIN 163 154 17 20
METOPROLOL SUCCINATE 156 151 18 9
CITALOPRAM HBR 149 149 19 25
QUETIAPINE FUMARATE 145 145 20 32
LACTULOSE 143 143 21 37
ZOLPIDEM TARTRATE 141 141 22 18
OXYCODONE-ACETAMINOPHEN 127 119 S2 23 26
DIVALPROEX SODIUM 127 127 23 41
ATORVASTATIN CALCIUM 127 121 23 12
DIGOXIN 123 123 26 34
TAMSULOSIN HCL 114 114 27 29
DIOVAN 110 104 28 17
CLOPIDOGREL 108 103 29 27
HYDROCHLOROTHIAZIDE 92 92 30 16
KLOR-CON M10 87 85 31 209
FLUTICASONE PROPIONATE 84 83 32 55
LEVOFLOXACIN 84 80 32 59
METFORMIN HCL 84 84 32 13
LOSARTAN POTASSIUM 81 77 35 23
RAMIPRIL 80 80 36 69
GENERLAC 77 77 37 129
PREDNISONE 75 74 38 58
PLAVIX 75 74 38 42
FENTANYL 73 73 S2 40 50
RISPERIDONE 70 70 41 31
LIDODERM 68 68 42 45
CARBIDOPA-LEVODOPA 67 60 43 48
FINASTERIDE 66 66 44 85
SPIRONOLACTONE 66 63 44 70
PRANDIN 64 50 46 147
DILTIAZEM HCL 64 64 46 183
TRAVATAN Z 63 63 48 79
ADVAIR DISKUS 60 59 49 46
ISOSORBIDE MONONITRATE ER 60 60 49 60
LEXAPRO 57 52 51 92
TRAZODONE HCL 56 56 52 38
OXYBUTYNIN CHLORIDE ER 56 56 52 96
TIMOLOL MALEATE 55 55 54 156
ENULOSE 53 53 55 162
POLYETHYLENE GLYCOL 3350 52 52 56 53
TRAMADOL HCL-ACETAMINOPHEN 51 50 57 81
SEROQUEL 51 51 57 106
CYMBALTA 50 50 59 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.